Mode
Text Size
Log in / Sign up

Automated insulin delivery systems improve time in range and reduce distress in older adults with type 1 diabetesAutomated insulin delivery systems help older adults with type 1 diabetes

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Consider automated insulin delivery systems for older adults with type 1 diabetes to improve time in range and reduce distress.

This meta-analysis evaluates the impact of automated insulin delivery (AID) systems on clinical outcomes in a population of 8,765 adults aged 60 years and older with type 1 diabetes. The analysis synthesized data on glycemic control and patient-reported outcomes to determine the efficacy of AID technology in older demographics.

Key findings include a mean time in range (TIR) of 77.95% (95% CI 75.31-80.59) and a mean HbA1c of 6.95% (52 mmol/mol) (95% CI 6.67-7.24). Additionally, the study reported a mean reduction in HbA1c from baseline of -0.36% (95% CI -0.63 to -0.09). Other outcomes included a time below range (TBR) < 70 mg/dL of 1.35% (95% CI 1.12-1.57). The analysis also noted lower levels of hyperglycemia and lower diabetes distress scores, with no reported increase in hypoglycemia.

Authors note that evidence regarding AID systems specifically for this older population remains limited and largely observational. Despite these limitations, the findings suggest that advanced age alone should not preclude the individualized use of AID systems. Clinical application should be tailored to individual patient needs.

How this fits prior evidence

This meta-analysis addresses a gap in evidence regarding the use of automated insulin delivery (AID) systems specifically in older populations with type 1 diabetes. While previous coverage noted that older patients with type 1 diabetes are more likely to be permitted to fast during Ramadan, this study provides specific data on the efficacy of AID systems in those same older patients. The findings suggest that advanced age is not a barrier to utilizing advanced technology to improve time in range and reduce distress.

Managing type 1 diabetes can be a constant, exhausting task, especially as people get older. For many adults over age 60, finding the right balance of insulin is a daily challenge. New data suggests that automated insulin delivery (AID) systems might offer a way to make this management more consistent and less stressful.

Researchers looked at data from over 8,000 older adults using these automated systems. The results showed that these patients spent a significant amount of time in their target blood sugar range. They also saw lower levels of high blood sugar and reported less diabetes distress, which is the emotional and physical strain of managing the condition.

While the results are encouraging, it is important to note that much of the current evidence for these systems in older adults comes from observational data. Because the evidence is still limited, doctors should work closely with patients to decide if an automated system is the right choice for their specific needs.

What this means for you:
Automated insulin systems can improve blood sugar levels and reduce stress for older adults with type 1 diabetes.

Common questions

How does automated insulin delivery help older adults?

Automated insulin delivery (AID) systems can help older adults with type 1 diabetes stay within a target blood sugar range. The data showed a time in range of 77.95% for those using these systems. These systems also helped lower instances of high blood sugar and reduced the overall stress of managing the condition.

Can these systems reduce the stress of managing diabetes?

Yes, the data indicates that patients using automated insulin delivery systems reported lower levels of diabetes distress. This means the emotional and physical burden of managing their daily insulin needs was reduced compared to previous measures.

Is it safe for older adults to use these systems?

The data showed no increased risk of low blood sugar (hypoglycemia) for older adults using these systems. However, because much of the evidence for this specific age group is still limited and observational, you should talk to your doctor to see if it is right for you.

Study Details

Study typeMeta analysis
Sample sizen = 8,765
EvidenceLevel 1
PublishedSep 2026
View Original Abstract ↓
Older adults with type 1 diabetes are clinically heterogeneous, with variable cognition, dexterity, comorbidity burden, caregiver support, and prior technology experience. Evidence on automated insulin delivery (AID) systems in this population remains limited and largely observational. We performed a systematic review and meta-analysis of contemporary AID systems in adults aged ≥60 years with type 1 diabetes. We searched PubMed, Embase, Web of Science, Cochrane Library, and ClinicalTrials.gov through February 2026. Nine studies (7 observational studies and 2 randomized crossover trials; 8,765 participants) were included. We pooled outcomes during AID use using single-arm random-effects meta-analyses. When baseline data were available, we performed change-from-baseline analyses. Pooled mean time in range (TIR) was 77.95% (95% CI 75.31-80.59), HbA1c was 6.95% (52 mmol/mol) (95% CI 6.67-7.24), and time below range (TBR) < 70 mg/dL was 1.35% (95% CI 1.12-1.57). From baseline, AID use was associated with higher TIR, lower hyperglycemia, lower HbA1c (MD - 0.36%; 95% CI - 0.63 to - 0.09), and lower diabetes distress, without increased hypoglycemia. Findings were consistent in direction with broader AID literature. Older age alone should not preclude individualized AID use.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.